Clinical impact of follow-up endomyocardial biopsy in myocarditis during or after immune-suppressive therapy.

ESC Heart Fail · 2025 · PMC12450759 · PMID 40583838

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

showed a trendP = 0.05actually significant

64%, P = 0.048) and showed a trend towards lower prevalence of anti‐heart auto‐antibodies positivity at diagnosis as compared with patients not receiving follow‐up EMB (47% vs. 71%, P = 0.05).

also in 47,213 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.